Results showed a significant reduction in risk for RA in patients treated with GLP-1 receptor agonists (HR = 0.87
Studies have found that people taking GLP-1s for obesity feel significantly less hungry and eat fewer calories typically around 16-39% less (4)
research and clinical opportunities to address weight stigma and foster health equity have been proposed [232]
As GLP-1RAs become more commonly used, clinicians need to monitor for AV dermatological side effects while planning suitable treatment approaches for patients who develop this condition
When you add rapid weight loss to the equation, youre asking skin to adapt faster than it biologically can
This guide covers everything Hashimoto's patients need to understand about GLP-1 therapy , from the research on safety and thyroid function to practical monitoring schedules, supplement considerations , medication timing, and the specific scenarios where these medications could genuinely help versus situations where caution is warranted
